Key facts
- Gaudium IVF and Women Health (NSE: GAUDIUMIVF)’s last known valuation is $63.3M (Feb 2026).
- It has raised $15.3M; the latest was IPO ($18.2M) in Feb 2026.
- Notable investors include Carnelian Asset Advisors, Hornbill Capital, Meru Investment Fund PCC, Sanshi Fund I.
- Status: Publicly Held.
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Gaudium IVF and Women Health (NSE: GAUDIUMIVF)
- ·The full record, as it builds
Funding rounds
No funding rounds for Gaudium IVF and Women Health (NSE: GAUDIUMIVF) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gaudium IVF and Women Health (NSE: GAUDIUMIVF)
Gaudium IVF And Women Health Ltd is engaged in the business of providing healthcare services mainly rendering various fertility treatments such as In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), Intracytoplasmic Sperm Injection (ICSI), Egg Freezing, and laser assisted embryo implantation, amongst others. The company derives the majority of its revenue from business of providing IVF treatment in bundled packages which includes injections, Ovum/Egg Pickup, Embryo Creation and Embryo Transfer.
- Sector
- Healthcare
- HQ
- New Delhi, India
- Founded
- 2015
- Employees
- 122
- Website
- gaudiumivfcentre.com/
- Ownership
- Publicly Held
Gaudium IVF and Women Health (NSE: GAUDIUMIVF) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gaudium IVF and Women Health (NSE: GAUDIUMIVF) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gaudium IVF and Women Health (NSE: GAUDIUMIVF) in its N-PORT filings yet. We sweep new filings monthly.